Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Medical Prognosis

Medical Prognosis
2004 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
OV STOCK SYMBOL
1 INVESTMENTS
$0.27 SHARE PRICE (As of Friday Closing)
Description

Oncology Venture AS, formerly Medical Prognosis Institute A/S, is engaged in the development of anticancer medicines. The Company's current priority program focus is for advancement of three precision medicine treatments: 2X-121, Dovitinib and Ixempra targeting the market for treatment of ovarian cancer, breast cancer and renall cell carcinoma. The company holds the rights to develop four additional precision medicine programs: LiPlaCis, Irofulven, APO010 and 2X-111.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
STO
Primary Office
  • Venlighedsvej 1
  • 2970 Hørsholm
  • Denmark

+45 21 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Medical Prognosis’s full profile, request a free trial.

Medical Prognosis Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.16 - $1.10 $34M $0.28 -$0.20 3.86M 121M

Medical Prognosis Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 23,316 36,655 32,928 60,908
Revenue 146 340 780 651
EBITDA (9,960) (3,290) (4,686) (2,064)
Net Income (11,045) (2,365) (4,607) (1,680)
Total Assets 37,714 38,527 2,093 2,316
Total Debt 5,951 2,894 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medical Prognosis Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000000 0 24-Aug-2018 000000000000000000 Drug Discovery
To view this company’s complete investment and acquisition history, request access »

Medical Prognosis Subsidiaries (1)

Company Name Industry Location Founded
00000000 0000000 0 Drug Discovery Hørsholm, Denmark 0000
To view this company’s complete subsidiary history, request access »